Dale Warfel
Overview
Explore the profile of Dale Warfel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kelly D, Sullivan K, McEvoy J, McMahon R, Wehring H, Gold J, et al.
J Clin Psychopharmacol
. 2015 Jun;
35(4):374-81.
PMID: 26082974
Objective: Clozapine is the most effective antipsychotic for treatment refractory people with schizophrenia, yet many patients only partially respond. Accumulating preclinical and clinical data suggest benefits with minocycline. We tested...
2.
Kelly D, Wehring H, Earl A, Sullivan K, Dickerson F, Feldman S, et al.
BMC Psychiatry
. 2013 Aug;
13:214.
PMID: 23968123
Prolactin elevations occur in people treated with antipsychotic medications and are often much higher in women than in men. Hyperprolactinemia is known to cause amenorrhea, oligomenorrhea, galactorrhea and gynecomastia in...
3.
Jackson J, Eaton W, Cascella N, Fasano A, Warfel D, Feldman S, et al.
Schizophr Res
. 2012 Jul;
140(1-3):262-3.
PMID: 22771303
No abstract available.
4.
Parwani A, Weiler M, Blaxton T, Warfel D, Hardin M, Frey K, et al.
Psychopharmacology (Berl)
. 2005 Oct;
183(3):265-74.
PMID: 16220331
Rationale: N-methyl-D: -aspartate (NMDA) glutamate receptor antagonists have been reported to induce schizophrenia-like symptoms in humans, including memory impairments. Although the NMDA receptor has been shown to impair memory acquisition...